Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CPEX Receives Letter from Athyrium Capital Management
Yahoo/BusinessWire
Saturday, March 5, 2011 - 12:25pm
tags:
CPEX Pharmaceuticals
Is Novartis the Right Stock to Retire With?
Motley Fool
Saturday, March 5, 2011 - 12:23pm
tags:
Novartis
Pomerantz Law Firm Reminds Shareholders of MannKind Corp of Upcoming Deadline
Yahoo/GlobeNewsWire
Saturday, March 5, 2011 - 12:22pm
tags:
MannKind, lawsuits
Amgen Completes Acquisition of BioVex
Yahoo/PR NewsWire
Saturday, March 5, 2011 - 12:09pm
tags:
Amgen, BioVex, M&A
Revenues Rise at Allos
Yahoo/Zacks
Saturday, March 5, 2011 - 12:08pm
tags:
Allos, earnings
How to Trade Biotech Stocks Better
Minyanville
Saturday, March 5, 2011 - 12:07pm
tags:
Gilead Sciences removes warning for Letairis
Yahoo/AP
Saturday, March 5, 2011 - 12:05pm
tags:
Gilead Sciences, Letairis
All Eyes Are On Roche, Avastin And Lucentis
Pharmalot
Friday, March 4, 2011 - 1:03pm
tags:
Roche, Avastin, Lucentis, diabetic macular edema
A Victory For Gilead
Forbes
Friday, March 4, 2011 - 1:01pm
tags:
Gilead Sciences, Myogen, HIV
BioSante expects to support drug study program with $23.8 million from direct stock offering
Yahoo/AP
Friday, March 4, 2011 - 1:00pm
tags:
BioSante, stock offering, Pfizer
Genzyme CEO: Sanofi to create jobs
Boston Herald, MA
Friday, March 4, 2011 - 10:44am
tags:
M&A, Genzyme, Sanofi, Henri Termeer
Merck Discriminated Against A Non-Hispanic Worker?
Pharmalot
Friday, March 4, 2011 - 10:42am
tags:
Merck, discrimination
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Bloomberg
Friday, March 4, 2011 - 10:40am
tags:
Vivus, birth defects, Topamax, JNJ, Qnexa
Somaxon's 4Q loss widens on higher costs
Yahoo/AP
Friday, March 4, 2011 - 10:39am
tags:
earnings, Somaxon
Sucampo reports loss on revenue dip, higher costs
Yahoo/AP
Friday, March 4, 2011 - 10:38am
tags:
earnings, Sucampo
No Serendipity Involved in Vertex's Achievements
Seeking Alpha
Friday, March 4, 2011 - 10:37am
tags:
Vertex Pharmaceuticals, VX-770, cystic fibrosis
Novartis Lung Treatment Faces Scrutiny in Second Review by FDA
Bloomberg
Friday, March 4, 2011 - 10:36am
tags:
Novartis, FDA, Arcapta Neohaler, asthma
Pfizer Says Primary Goal Met in Tofacitinib Trial
Bloomberg
Friday, March 4, 2011 - 10:34am
tags:
Pfizer, rheumatoid arthritis, tofacitinib
Pfizer: The Market's Undervalued Ugly Duckling
Seeking Alpha
Friday, March 4, 2011 - 10:33am
tags:
Pfizer, Lipitor
FDA warns of birth defects with Topamax
Yahoo/AP
Friday, March 4, 2011 - 10:33am
tags:
FDA, Topamax, epilepsy, birth defects

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.